Wednesday, June 16, 2010

FDA to Hear From Women's Group Urging Opposition to Abortion Drug Ella

Washington, DC ( -- The head of a women's organization will be testifying at a Food and Drug Administration hearing on Thursday and telling federal officials the drug agency should not approve the abortion drug Ella. Known as ellaOne in Europe and by its name ulipristal, it operates like the popular abortion drug RU 486.

Despite its abortifacient properties, the Ella drug would be marketed in the United States as a new and improved version of the morning after pill. Full story.

No comments: